Chicago, IL 的 克隆氏症 臨床試驗
9 項針對 克隆氏症 的研究正在 Chicago（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- University of Chicago Medical Center ( Site 5066), Chicago
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- University of Chicago Medical Center /ID# 267400, Chicago
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Rush University Medical Center, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Rush University Medical Center-Site Number: 8400015, Chicago
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
招募中2 期
- Rush University Medical Center, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
招募中2 期
- Rush University Medical Center, Chicago
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- University of Chicago Medicine, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
招募中
- University of Chicago Medicine, Chicago
Treatment of Moderate to Severe Refractory Crohn's Disease
招募中1/2 期
- Northwestern, Chicago
- University of Chicago, Chicago
其他城市的 克隆氏症 試驗
- New York City, NY35 項研究
- Boston, MA19 項研究
- Miami, FL19 項研究
- Cleveland, OH19 項研究
- St. Louis, MO19 項研究
- Tyler, TX17 項研究
- Orlando, FL17 項研究
- Houston, TX17 項研究
- Atlanta, GA17 項研究
- San Antonio, TX15 項研究
- Los Angeles, CA15 項研究
- San Diego, CA15 項研究
Chicago 的其他研究
- 非小細胞肺癌61 項研究
- 乳癌59 項研究
- 癌症（所有類型）51 項研究
- 轉移性癌症45 項研究
- 前列腺癌45 項研究
- 肺癌41 項研究
- 肥胖症41 項研究
- 卵巢癌36 項研究
- 大腸直腸癌34 項研究
- 中風34 項研究
- 心臟衰竭31 項研究
- 過重29 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。